T3N2b right BOT HPV+ SCC, non-smoker, on OPTIMA trial, s/p induction chemotherapy with carboplatin/abraxane followed by 5/5 cycles of TFHX completed on 11/11/16. The images are degraded by patient motion. There are post-treatment findings without evidence of measurable residual oropharyngeal tumor. The irregular right level 2A lymph node is no longer discernible and a right level 3 lymph node measures 8 x 9 mm, previously 9 x 14 mm. The left cervical lymph nodes are not particularly enlarged. The salivary glands are unremarkable. There is mild degenerative spondylosis at C4-5 and C5-6. There is a subcentimeter left maxillary sinus retention cyst. The orbits and imaged intracranial structures are grossly unremarkable.
1. Post-treatment findings without evidence of measurable residual oropharyngeal tumor, although the images are degraded by patient motion. 2. No evidence of significant residual cervical lymphadenopathy, although the images are degraded by patient motion. 